Vericel Corp. (VCEL)
57.42
-2.03
(-3.41%)
USD |
NASDAQ |
Nov 12, 16:00
57.40
-0.02
(-0.03%)
After-Hours: 20:00
Vericel Total Assets (Quarterly) : 517.11M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 517.11M |
| June 30, 2026 | 502.87M |
| March 31, 2026 | 485.63M |
| December 31, 2025 | 487.97M |
| September 30, 2025 | 453.27M |
| June 30, 2025 | 435.61M |
| March 31, 2025 | 424.59M |
| December 31, 2024 | 432.72M |
| September 30, 2024 | 390.40M |
| June 30, 2024 | 376.84M |
| March 31, 2024 | 356.66M |
| December 31, 2023 | 353.66M |
| September 30, 2023 | 318.12M |
| June 30, 2023 | 310.71M |
| March 31, 2023 | 265.10M |
| December 31, 2022 | 273.00M |
| September 30, 2022 | 248.02M |
| June 30, 2022 | 244.82M |
| March 31, 2022 | 240.29M |
| December 31, 2021 | 243.70M |
| September 30, 2021 | 224.14M |
| June 30, 2021 | 221.94M |
| March 31, 2021 | 211.46M |
| December 31, 2020 | 205.61M |
| September 30, 2020 | 157.50M |
| Date | Value |
|---|---|
| June 30, 2020 | 146.69M |
| March 31, 2020 | 150.26M |
| December 31, 2019 | 153.24M |
| September 30, 2019 | 137.53M |
| June 30, 2019 | 125.83M |
| March 31, 2019 | 141.23M |
| December 31, 2018 | 118.69M |
| September 30, 2018 | 124.46M |
| June 30, 2018 | 122.19M |
| March 31, 2018 | 52.41M |
| December 31, 2017 | 54.58M |
| September 30, 2017 | 40.28M |
| June 30, 2017 | 36.53M |
| March 31, 2017 | 40.59M |
| December 31, 2016 | 48.60M |
| September 30, 2016 | 28.02M |
| June 30, 2016 | 29.43M |
| March 31, 2016 | 33.06M |
| December 31, 2015 | 34.31M |
| September 30, 2015 | 35.82M |
| June 30, 2015 | 41.22M |
| March 31, 2015 | 44.49M |
| December 31, 2014 | 47.58M |
| September 30, 2014 | 50.38M |
| June 30, 2014 | 19.84M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.794B |
| Alnylam Pharmaceuticals, Inc. | 7.995B |
| Anika Therapeutics, Inc. | 189.60M |
| Savara, Inc. | 155.93M |
| Biogen, Inc. | 32.05B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 132.94M |
| Shareholders Equity (Quarterly) | 384.17M |
| Debt to Equity Ratio | 0.241 |
| Current Ratio | 5.131 |
| Net Debt Paydown Yield | 0.09% |